India Pharma 2026 highlights policy push, innovation driving sectoral growth
India is poised to lead the global pharma landscape with a focus on biosimilars and specialty medicines stressed J.P. Nadda, Union…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Pharma firms accelerate regional capacity building to secure GLP-1 supply and mitigate geopolitical…
GlobalData highlights shift towards localised manufacturing, inventory security, and diversified supply networks to address rising…
Merck signs MoU with MAHE to expand healthcare R&D talent development in India
Catalyst training programme launched to link academic learning with industry requirements
The GLP-1 revolution
A new class of drugs is reshaping global health,but India’s generics wave could change who benefits. Dr Rajpushpa Labh,Consultant…
India brings together a rare and powerful combination of capabilities
Dr Kshitij Panse,Chief Operation Officer,GATINN by Servier,in an interaction with Kalyani Sharma, discusses the strategic…
Foundayo, Lilly’s new oral GLP-1 pill for weight loss, now available in US
Eli Lilly and Company announced that Foundayo (orforglipron) is now available to adults with obesity or overweight with…
OPPI collaborates with NIPER Rae Bareli to advance research excellence
The Organisation of Pharmaceutical Producers of India (OPPI) has announced a strategic collaboration with the National Institute…
Merck expands Bengaluru facility to boost global supply of filtration devices
Merck, a leading science and technology company, announced the expansion of its manufacturing facility in Peenya, Bengaluru. The…
Lupin receives ANDA approval for Dapagliflozin, Metformin Hydrochloride extended-release tablets in…
Global pharma major Lupin Limited (Lupin) today announced that it has received approval from the United States Food and Drug…
Glenmark receives US FDA approval for Progesterone Vaginal Inserts, 100 mg
Glenmark Pharmaceuticals has received final approval from the United States Food & Drug Administration (US FDA) for…
Lupin receives US FDA approval for Dapagliflozin tablets
Approval confirms bioequivalence to Farxiga for approved indications
Inventia enters the U.S. market with FDA approved Dapagliflozin tablets
Approval grants eligibility for 180-day shared generic drug exclusivity
Biocon launches Bosaya and Aukelso in the United States
Denosumab biosimilars made available through specialty pharmacies and healthcare providers
Alembic Pharmaceuticals secures USFDA approval for Dapagliflozin Tablets ANDA
Approval grants eligibility for 180-day shared generic drug exclusivity
Lupin receives Great Place To Work certification across global operations
Recognition based on study covering subsidiaries and employee participation
CuraTeQ Biologics reports Phase 3 results for BP11 biosimilar to Xolair
Study meets primary endpoints in chronic spontaneous urticaria across Europe and India
Bayer revises access model for Eylea 2mg in India to expand patient eligibility
Company aims to lower upfront cost to support early treatment initiation for retinal diseases
Leading people in the age of AI
As AI reshapes pharma, HR leadership is being drawn into a deeper question that goes beyond technology to the future of people and…
Patent expiries ahead, is India Pharma Inc ready?
Beyond the semaglutide momentum, a larger wave of patent expiries is set to unfold between 2026 and 2032. For Indian pharma, the…
Emcure Pharmaceuticals revises price of Poviztra semaglutide injection in India
Weight management drug to be available from Rs 3,999 per month from April 3, 2026